TBX-3400

· Taiga Biotechnologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TBX-3400, covering 2022-02-02 to 2022-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies [Phase 1, Phase 2]

See pricing